Patent · US Active

Hexokinase 2-specific inhibitors for use in acute central nervous system injury

US11584802B2 · kind B2 · utility

1Cited by

0References

3Claims

0Family size

Assignee

GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD · CN

Inventors

Guangmei Yan · 流花街道, CN
Wei Yin · 流花街道, CN
Yuan Li · Shandong, CN
Bingzheng Lu · Longbeilingcun, CN
Longxiang Sheng · Longbeilingcun, CN

Key dates

Filing date	Feb 6, 2018
Grant date	Feb 21, 2023
Priority date	—
Expiry date	Jun 10, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are applications of a hexokinase 2-specific inhibitor in preparing a medicament for preventing and treating acute central nervous system injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.